Comparing two liquid forms of an experimental antiviral medication in healthy adults
This is a Phase 1 study to see how well a new oral liquid form of an antiviral medicine is absorbed in healthy adults. Participation involves taking two versions of the medicine and monitoring your health, which helps researchers find the best formulation for future use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are a healthy adult without major medical conditions.
- Your weight is at least 50 kg (men) or 45 kg (women), and your body mass index is between 18 and 28.
- You have not taken any medications (including over-the-counter drugs or herbal supplements) in the last 2 weeks.
- You can commit to avoiding alcohol, smoking, certain foods (like grapefruit), and strenuous exercise before and during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two versions of an antiviral medicine called Ingavirin to see how your body processes them and whether they are safe. Researchers will give you the medicine on an empty stomach and after eating to understand how food affects how your body absorbs it.
This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.
This trial compares two different forms of a medication to see how they are absorbed and processed by the body and to check that they are safe. It is an early-stage study in healthy volunteers.
This study tests a new oral drug to see if it is safe and how the body processes it. It is for healthy adults without HIV, and results will help determine if the drug could be used for HIV prevention in the future.
This study checks if a new injectable medication (RAY1225) behaves the same in the body as the original version. It is for healthy adults and will compare the two forms to make sure they are alike.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.